This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Maria Larsson: Innovator in Enantiomerically Enriched Compounds
Introduction
Maria Larsson is a notable inventor based in Södertälje, Sweden. She has made significant contributions to the field of chemistry, particularly in the preparation of enantiomerically enriched compounds. Her work is essential for developing pharmacological agents that address insulin resistance syndrome.
Latest Patents
Maria holds a patent for a process that defines novel resolution methods. This invention is particularly focused on the preparation of the (S)-enantiomer of certain 2-ethoxy-3-(4-hydroxyphenyl)propanoic acids and their derivatives. The implications of her work are profound, as these compounds can be instrumental in treating conditions related to insulin resistance.
Career Highlights
Throughout her career, Maria has worked with prominent companies such as AstraZeneca AB and Sleep Cycle AB. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in pharmaceutical research and development.
Collaborations
Maria has collaborated with esteemed colleagues, including Panagiotis Ioannidis and Alan Eric Fischer. These partnerships have enriched her research and expanded the impact of her inventions in the scientific community.
Conclusion
Maria Larsson is a pioneering inventor whose work in enantiomerically enriched compounds has the potential to transform treatments for insulin resistance syndrome. Her contributions to the field of chemistry are invaluable, and her collaborations further enhance the significance of her innovations.